期刊文献+

荧光原位杂交技术检测尿液脱落上皮细胞染色体畸变对膀胱癌的诊断价值 被引量:3

Diagnostic value of chromosome aberration of urine exfoliated cells by fluorescence in situ hybridization for bladder carcinoma
原文传递
导出
摘要 目的探讨应用荧光原位杂交(FISH)技术检测尿液脱落上皮细胞3、7、9、17号染色体畸变对于膀胱癌诊断的价值。方法分别对30例膀胱癌患者和20例非肿瘤血尿患者应用FISH试剂盒检测膀胱癌,使用荧光标记的DNA探针与3、7和17号染色体的着丝粒区以及9p21位点相结合,检测尿路上皮细胞基因的改变。在组织学诊断的基础上评估FISH检测的价值。结果30例膀胱癌患者FISH检测的特异性和敏感性分别为100%和97%。结论FISH是一种无创的膀胱癌诊断方法,具有快速、准确、灵敏度高的优点,对膀胱癌的诊断具有重要的临床应用价值。 Objective To evaluate the diagnostic value of chromosome aberration of urine exfoliated cells by fluorescence in situ hybridization (FISH)for patients with bladder carcinoma. Methods Using centromeric probes of chromosomes 3, 7, 17 and region probe of 9p21, we performed FISH on the exfoliative cells in the urinary samples from 30 patients with pathologically confirmed bladder .carcinoma and 20 hematuria patients with benign bladder disease controls. Then we noted and analyzed aberrations in the chromosomes. Results The sensitivity and specificity of FISH on detecting bladder cancer were 97% and 100% , respectively. Conclusions It is noninvasive and effective to diagnose bladder cancer with the techiqtre of FISH. It is a rapid, accurate and very sensitive method and can be used in clinical diagnosis.
出处 《中国实用医刊》 2011年第1期4-6,9,共4页 Chinese Journal of Practical Medicine
基金 基金项目:河南省医学科技攻关资助课题(201004022),郑州市创新型科技人才队伍建设工程
关键词 膀胱癌 荧光原位杂交 细胞学 Bladder carcinoma Fluorescence in situ hybridization Cytology
  • 相关文献

同被引文献25

  • 1Hungerhuber E,Stepp H,Kriegmair M,et al.Seven years experi-ence with 5-amin olevulinic acid in detection of transitional cell carci-noma of the bladder[J].Urology,2007,69(2):260-264.
  • 2Hajdinjak T.UroVysion FISH test for detecting urothelial cancers:Meta-analysis of diagnostic accuracy and comparison with urinary cy-tology testing[J].Urol Oncol,2008,26(6):646-651.
  • 3Kipp B R,Karnes R J,Brankley S M,et a1.Monitoring intravesicaltherampy for supericial bladder cancer using fluorescence in situ hy-bridization[J].J Urol,2005,173(2):40l-404.
  • 4Friedrich M G,Toma M I,Hellstern A,et a1.Comparison of multitar-get fluorescence in situ hybridization in urinne with other noninvasivetests for detecting bladder cancer[J].BJU Int,2003,92(9):911-914.
  • 5Sarosdy M F,Schellhammer P,Bokinsky G,et al.Clinical evaluationof a multi-target fluorescent in situ hybridization assay for detection ofbladder cancer[J].J Urol,2002,168(5):1950-1954.
  • 6Zellweger T,Benz G,Cathomas G,et al.Multi-target fluorescence insitu hybridization in bladder washings for prediction of recurrent blad-der cancer[J].Int J Cancer,2006,119(7):1660-1665.
  • 7Yoder B J,Skacel M,Hedgepeth R,et a1.Reflex UroVysion testing ofbladder cancer surveillance patients with equivocal or negative urinecytology:a prospective study with focus on the naturahistory of antici-patory positive findings[J].Am J Clin Pathol,2007,127(2):295-301.
  • 8Grossman HB, Messing E, Soloway M, et al. Detection of bladder cancer using a point-of-care proteomic assay [ J]. JAMA, 2007, 293(7) :810-816.
  • 9J.Y. Ro, G.A. Staerkel, A.G. Ayala, Cytologic and histologic features of superficial bladder cancer [J]. Urol Clin North Am. 1992, 19(3): 435-453.
  • 10Whitson J, Berry A, Carroll P, et al. A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy [J]. BJU Int, 2009, 104(3): 336-339.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部